PREDICT — Pathway of Research to Evaluation of Dose-Individualised Cancer Therapy: Development of a national individualised cancer-dosing program to both generate evidence and implement existing evidence on algorithms for dosing targeted and non-targeted chemotherapy.

The Pathways Program will comprehensively address the issue of optimal dosing for cancer patients and develop new strategies using modern dosing support systems to implement dose individualisation across large geographical distances.